First-line serplulimab and bevacizumab combined with nab-paclitaxel/gemcitabine followed by mFOLFOX in advanced pancreatic cancer: A phase II trial.Jieer Ying, Yunben Yang, Lei Zhang et al.|Journal of Clinical Oncology|2025Cited by 1